> For the complete documentation index, see [llms.txt](https://docs.syndromics.xyz/llms.txt). Markdown versions of documentation pages are available by appending `.md` to page URLs; this page is available as [Markdown](https://docs.syndromics.xyz/introduction/why-now.md).

# Why now

Three things had to be true before a protocol like Syndromics could work: tokenized stocks had to exist as ordinary on-chain assets with reliable pricing, there had to be real demand for RWAs as collateral, and the existing lending designs had to leave a gap worth filling. All three are true today.

## Tokenized stocks are now a real asset class

Non-stablecoin, transferable RWAs on public chains went from roughly $7.9B at the end of 2024 to about $21B at the start of 2026 and about $38.7B today. Tokenized stocks are the fastest-growing category within that.

| Category (rwa.xyz, 28 Aug 2026) | On-chain, transferable value | Notes                                                                                         |
| ------------------------------- | ---------------------------- | --------------------------------------------------------------------------------------------- |
| Stablecoins                     | \~$303B                      | The settlement layer                                                                          |
| Tokenized US Treasuries         | \~$16.0B                     | USYC $2.9B, BUIDL $2.8B, USDY $2.2B, BENJI \~$2.4B                                            |
| Tokenized credit                | \~$7.5B distributed          | About $35B if non-transferable "represented" assets such as Figure HELOCs are counted         |
| Commodities                     | \~$3.1B                      | XAUT, PAXG                                                                                    |
| **Tokenized stocks**            | **\~$2.6B**                  | Ondo Stocks above $1B TVL; xStocks above $25B cumulative volume; Robinhood, Coinbase, Binance |
| Private equity and VC           | \~$1.6B                      |                                                                                               |
| Real estate                     | \~$175M                      |                                                                                               |

Tokenized stocks alone went from about $424M in mid-2025 to about $2.59B in August 2026. Figures vary by around 20 percent between sources depending on whether non-transferable assets are counted.

## RWAs are being used as collateral, and demand is growing

While overall DeFi deposits contracted by about 15 percent over the year, RWA deposits into DeFi lending tripled to $7.4B (CoinShares, Q2 2026).

* **Aave Horizon**: about $540M supplied and $163M borrowed against permissioned treasury and CLO tokens by mid-2026.
* **Morpho**: RWA deposits went from near zero to about $400M during 2025, reached about $875M on Avalanche by March 2026, and about $80M to $90M is already live on Robinhood Chain.
* **Tokenized-stock collateral on Solana** (Kamino, Jupiter Lend): about $53M by late July 2026. Small, because pooled markets have to cap single-stock exposure aggressively.

For scale, US margin debt alone is above $900B and global securities-backed lending is a multi-trillion-dollar business, run almost entirely by prime brokers and private banks for wealthy clients.

## Robinhood Chain removes the last blocker

Robinhood Chain reached mainnet on 1 July 2026. It is the only L2 where a regulated broker issues 1:1-backed tokenized stocks as plain ERC-20s, with Chainlink 24/5 price feeds, ERC-4337 account abstraction and permissionless contract deployment. Robinhood itself describes the tokens as usable for "lending pools and trading collateral". See [Why Robinhood Chain](/robinhood-chain/why-robinhood-chain.md).

## Pooled markets leave the long tail unserved

Almost all on-chain lending against RWAs is pooled (Aave Horizon, Morpho vaults, Kamino). Pooled markets:

* price every borrower off the same utilisation curve regardless of collateral quality,
* socialise bad debt across all suppliers,
* have to cap or exclude anything that is not deeply liquid.

That is fine for treasuries and index ETFs. It does not serve a holder of a single mid-cap stock token who wants a 30-day loan at a rate a specific lender is happy with. Per-loan pricing, fixed terms and isolated exposure are the tools for that, and they are what Syndromics provides. See [Design principles](/introduction/design-principles.md).

## What went wrong before, and why it will not repeat here

The last cycle of RWA credit left a clear record: uncollateralised loans to opaque borrowers, covenants that could not be enforced from a chain, concentrated obligors and manipulated wrapper prices. Syndromics accepts only overcollateralised loans against liquid, oracle-priced, on-chain collateral, so recovery is a smart-contract liquidation rather than a legal process. The case studies are in [Lessons from RWA lending](/risk/lessons.md).


---

# Agent Instructions
This documentation is published with GitBook. GitBook is the documentation platform designed so that both humans and AI agents can read, navigate, and reason over technical content effectively. Learn more at gitbook.com.

## Querying This Documentation
If you need additional information that is not directly available in this page, you can query the documentation dynamically by asking a question.

Perform an HTTP GET request on the current page URL with the `ask` query parameter, and the optional `goal` query parameter:

```
GET https://docs.syndromics.xyz/introduction/why-now.md?ask=<question>&goal=<endgoal>
```

`ask` is the immediate question: it should be specific, self-contained, and written in natural language.
`goal` is optional and describes the broader end goal you are ultimately trying to accomplish on behalf of the user. GitBook uses it to tailor the answer towards what is most useful for that goal.

The response will contain a direct answer to the question and relevant excerpts and sources from the documentation.

Use this mechanism when the answer is not explicitly present in the current page, you need clarification or additional context, or you want to retrieve related documentation sections.
